CAS 1610882-30-8

TCS-OX2-29 HCl

Description:

TCS-OX2-29 HCl, identified by its CAS number 1610882-30-8, is a chemical compound that belongs to a class of substances known for their potential applications in medicinal chemistry and pharmacology. While specific details about its characteristics may not be widely available, compounds of this nature typically exhibit properties such as solubility in water or organic solvents, depending on their molecular structure and functional groups. The hydrochloride (HCl) form suggests that it is a salt, which often enhances the stability and solubility of the compound in various solvents. Additionally, TCS-OX2-29 HCl may possess biological activity, making it of interest for research in drug development, particularly in targeting specific biological pathways or diseases. As with many chemical substances, safety data sheets and handling guidelines should be consulted to ensure proper safety measures are taken when working with this compound. Further characterization would typically involve techniques such as NMR, mass spectrometry, and chromatography to elucidate its structure and purity.

Formula: C₂₃H₃₂ClN₃O₃

Synonyms:

• TCS-OX2-29 HCl
• TCSOX229 HCl,TCS-OX-2-29 HCl,TCS OX2 29 HCl
• (2S)-1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3,3-dimethyl-2-(pyridin-4-ylmethylamino)butan-1-one:hydrochloride

TCS-OX2-29

CAS: 1610882-30-8

Formula: C₂₃H₃₂ClN₃O₃

Purity: 98%

Molecular weight: 433.9715

Ref: IN-DA001VM8

TCS OX2 29

CAS: 1610882-30-8

TCS OX2 29 is a vasoactive intestinal peptide (VIP) receptor agonist that has been shown to have analgesic effects in rats. TCS OX2 29 is an excitatory neurotransmitter, which may be due to its ability to stimulate the release of glutamate and increase the activity of postsynaptic receptors. TCS OX2 29 also has a significant interaction with antinociceptive drugs such as morphine, which may be due to its ability to activate opioid receptors. Patch-clamp experiments on tegmental neurons have shown that TCS OX2 29 increases the frequency of spontaneous action potentials in these cells. It also induces locomotor activity in mice and pain hypersensitivity in rats. TCS OX2 29 has been used as an experimental model for symptoms associated with Parkinson’s disease, such as akinesia and muscle rigidity.

Formula: C₂₃H₃₁N₃O₃·HCl

Purity: Min. 95%

Molecular weight: 433.97 g/mol

Ref: 3D-KPC88230

TCS-OX2-29 HCl

CAS: 1610882-30-8

TCS-OX2-29 is a selective orexin-2 receptor antagonist (IC50 = 40 nM), which plays an important role in pain modulation.

Formula: C₂₃H₃₂ClN₃O₃

Purity: 98%

Color and Shape: Solid

Molecular weight: 433.97

Ref: TM-T4965L